Teva loses TM appeal over ‘French version’ of slogan

Drug company Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the EU General Court ruled in favour of the European Union IP Office (EUIPO) yesterday, July 8.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Teva withdraws Shield patent oppositions

19 October 2020 Israeli generics company Teva has withdrawn its oppositions to two patents owned by Shield Therapeutics before the European Patent Office.

Big Pharma

European Commission calls out Teva over anti-competitive practice

18 July 2017 The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.

Big Pharma

EIP hires Teva litigator

7 January 2014 EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.

More on this story

Big Pharma

Teva withdraws Shield patent oppositions

19 October 2020 Israeli generics company Teva has withdrawn its oppositions to two patents owned by Shield Therapeutics before the European Patent Office.

Big Pharma

European Commission calls out Teva over anti-competitive practice

18 July 2017 The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.

Big Pharma

EIP hires Teva litigator

7 January 2014 EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.

More on this story

Big Pharma

Teva withdraws Shield patent oppositions

19 October 2020 Israeli generics company Teva has withdrawn its oppositions to two patents owned by Shield Therapeutics before the European Patent Office.

Big Pharma

European Commission calls out Teva over anti-competitive practice

18 July 2017 The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.

Big Pharma

EIP hires Teva litigator

7 January 2014 EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.